Ustekinumab, Biosimilars Have Similar Medicare Part D Costs

Medicare Part D covers ustekinumab biosimilars, but patients pay nearly the same out-of-pocket costs regardless of the drug price and insurers rarely provide coverage for their affiliated biosimilars. Medscape Medical News